|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1036985963 |
003 |
OCoLC |
005 |
20231120010255.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
180521s2018 enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d YDX
|d OPELS
|d OCLCF
|d OTZ
|d MERER
|d INT
|d SNK
|d OCLCQ
|d U3W
|d OCLCQ
|d LVT
|d CQ$
|d OCLCQ
|d D6H
|d N$T
|d LQU
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d CASUM
|d OCLCO
|
019 |
|
|
|a 1037284198
|a 1037893049
|a 1105182360
|a 1105567502
|a 1229877818
|
020 |
|
|
|a 9780128123294
|q (electronic bk.)
|
020 |
|
|
|a 012812329X
|q (electronic bk.)
|
020 |
|
|
|z 9780128122150
|
020 |
|
|
|z 0128122153
|
035 |
|
|
|a (OCoLC)1036985963
|z (OCoLC)1037284198
|z (OCoLC)1037893049
|z (OCoLC)1105182360
|z (OCoLC)1105567502
|z (OCoLC)1229877818
|
050 |
|
4 |
|a QH450
|
072 |
|
7 |
|a SCI
|x 029000
|2 bisacsh
|
082 |
0 |
4 |
|a 572.865
|2 23
|
245 |
0 |
0 |
|a Epigenetics in Human Disease /
|c edited by Trygve O. Tollefsbol.
|
264 |
|
1 |
|a London :
|b Academic Press,
|c [2018]
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Translational epigenetics ;
|v v. 6
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed May 22, 2018).
|
520 |
|
|
|a Epigenetics in Human Disease, Second Edition examines the diseases and conditions on which we have advanced knowledge of epigenetic mechanisms, such as cancer, autoimmune disorders, aging, metabolic disorders, neurobiological disorders and cardiovascular disease. In addition to detailing the role of epigenetics in the etiology, progression, diagnosis and prognosis of these diseases, novel epigenetic approaches to treatment are also explored. Fully revised and up-to-date, this new edition discusses topics of current interest in epigenetic research, including stem cell epigenetic therapy, bioinformatic analysis of NGS data, and epigenetic mechanisms of imprinting disorders. Further sections explore online epigenetic tools and datasets, early-life programming of epigenetics in age-related diseases, the epigenetics of addiction and suicide, and epigenetic approaches to regulating and preventing diabetes, cardiac disease, allergic disorders, Alzheimer's disease, respiratory diseases, and many other human maladies.
|
650 |
|
0 |
|a Epigenetics.
|
650 |
|
0 |
|a Medical genetics.
|
650 |
|
2 |
|a Genetics, Medical
|0 (DNLM)D005826
|
650 |
|
6 |
|a �Epig�en�etique.
|0 (CaQQLa)000270630
|
650 |
|
6 |
|a G�en�etique m�edicale.
|0 (CaQQLa)201-0001432
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Genetics & Genomics.
|2 bisacsh
|
650 |
|
7 |
|a Epigenetics
|2 fast
|0 (OCoLC)fst01893642
|
650 |
|
7 |
|a Medical genetics
|2 fast
|0 (OCoLC)fst01014133
|
655 |
|
4 |
|a Internet Resources.
|
655 |
|
4 |
|a Charts.
|
700 |
1 |
|
|a Tollefsbol, Trygve O.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|z 0128122153
|z 9780128122150
|w (OCoLC)1020030953
|
830 |
|
0 |
|a Translational epigenetics series ;
|v v. 6.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128122150
|z Texto completo
|